Silencing of survivin and cyclin B1 through siRNA-loaded arginine modified calcium phosphate nanoparticles for non-small-cell lung cancer therapy
Publication date: Available online 27 August 2020Source: Colloids and Surfaces B: BiointerfacesAuthor(s): Goknur Kara, Ayhan Parlar, Melike Cokol Cakmak, Murat Cokol, Emir Baki Denkbas, Feray Bakan
Source: Colloids and Surfaces B: Biointerfaces - Category: Biochemistry Source Type: research
More News: Biochemistry | Calcium | Cancer | Cancer & Oncology | Cancer Therapy | Lung Cancer | Nanotechnology | Non-Small Cell Lung Cancer